A. Retracted, “EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS”, Asian J Pharm Clin Res, vol. 10, no. 3, pp. 300–307, Mar. 2017.